Well-designed clinical trials are essential to provide the evidence needed for rational treatment choices. Clinical trials of antiseizure treatments conducted in the past have many shortcomings, and there is a lack of randomized trials in the majority of epilepsy syndromes. There is a need for stakeholders to promote high quality trials in epilepsy, ideally through establishment of international collaborative networks of qualified investigators.
Similar issues are to be considered when designing and performing trials within the epilepsy-surgery indications and outcomes.
Based on these premises, a group of European clinical investigators with a special interest in the treatment of epilepsy established a collaborative group named European Collaboration for Epilepsy Trials (ECET) with the goal of promoting and improving the quality of collaborative epilepsy trials in Europe, in both adults and children.
ECET is formally operating within the framework of Epilepsy Alliance Europe (EAE), a non-for-profit organization registered in Ireland that brings together European professional and lay stakeholders associated with the International League Against Epilepsy (ILAE) and with the International Bureau for Epilepsy (IBE) to promote prevention, treatment and research of epilepsy.
ECET participants are mostly affiliated with EpiCARE (see the list of EpiCARE members here), particularly those involved with the Working Group on Clinical Trials and Targeted Therapies. The group also includes experienced investigators outside EpiCARE, including those based in other than EU countries in the European region.
Their role will include reviewing processes, considering the needs of the epilepsy community as a whole.
The patient perspective (such as the risk/benefit balance and the potential burden of trials for caregivers and patients) is paramount to design efficient clinical trials and definition of expected outcomes.
ECET encourages patient representatives’ involvement in research, as they provide a unique perspective on the unmet needs of patients and their caregivers.
A list of participating patient representives will be available soon.
To learn more about ECET and the challenges of epilepsy trials in Europe, watch this webinar by Julius Clinical.
During this webinar, hosted by Dr. Lieza G. Exalto, Prof. Jacqueline French, Prof. Alexis Arzimanoglou and Prof. Eugen Trinka discussed:
> Experiences of the US Epilepsy Consortium
> What is the role of European Reference Network EpiCARE in Epilepsy Trials
>The added value of the European Collaboration for Epilepsy Trials (ECET) consortium
ECET is governed by Alexis Arzimanoglou and Eugen Trinka, with Reetta Kälviäinen as the treasurer, and Philippe Ryvlin as secretary.
The Coordinating Committee is composed of:
Project Manager: Sebile Tchaicha
If you are a medical team with recognized expertise wishing to join ECET , or an industry professional / investigator wishing to use ECET’s service, please do not hesitate to contact Sebile Tchaicha, ECET Project manager.
Experts from these institutions constitute the driving task force of ECET: